Rhubarb-Evoke Mucus Secretion through Aggregation and Degranulation of Mast Cell in the Colon of Rat: In vivo and ex vivo studies

Abstract

Rhubarb is commonly used to treat constipation in China for its function of promoting intestinal movement and optimum water content in feces. However, its mechanism of mucus secretion is vague. The aim of the study is to investigate the role of mast cells and enteric neurons in rhubarb extract (RE)-induced mucus secretion in the rat colon. Immunofluorescence was used to detect histamine receptors. Western blotting and 3,3′-diaminobenzidine (DAB) were applied to explore the content changes of mast cells activation. The changes in colonic goblet cells (GCs) were determined by means of PAS/AB staining. An intestinal perfusion system with a Bradford protein assay kit was directly to estimate in vitro secretion. And the cytokines were investigated with ELISA. The longitudinal aspect of this study indicate that the number and water content of faecal pellets were enhanced after the administration of different doses of RE accompanied by mast cells accumulated and increased the content of interferon (IFN) -γ or decreased the levels of interleukin (IL) −10 at doses of 3 and 6 g/kg. Pretreatment with ketotifen, mast cell stabilizer, had partially inhibited on RE-induced mucus secretion. Furthermore, RE induced the release of acetylcholine and mucin-2 in the colonic tissue and the histamine levels from the faeces. The results suggest that RE induced colonic mucus secretion involves mast cell activation and some cytokine.

Introduction

Rhubarb, as a species of Polygonaceae, has been clinically used for fever, diarrhoea, detoxification and detumescence in Traditional Chinese medicine (TCM) for thousands of years. Besides being used as a laxative, rhubarb also plays an important role in protecting the gut barrier, maintaining the intestinal micro-ecological environment and preventing bacterial translocation1,2. The main roles of rhubarb are attributed to its 2–5% content of anthraquinone derivatives3, which include rhein, emodin, chrysophanol, aloe-emodin, and physcion4. Rhubarb has been found to increase intestinal water content and ion secretion, which may contribute to relieve constipation5. Furthermore, anthraquinone as the main active ingredient of rhubarb root extract, augments rat ileal contraction by triggering release of endogenous acetylcholine6. Our previous study showed that emodin stimulates rat colonic epithelial Cl secretion, which is predominantly mediated by endogenous prostaglandin release and histamine7. At present, preparations containing rhubarb in chinese pharmacopoeia only achieve purgative efficacy for its free anthraquinones with its stimulate the colon plexus and inhibit Na+-K+-ATPase8. As it is well known that most mucin secreted by goblet cells (GCs) produced in the gastrointestinal tract, a diverse family of densely glycosylated proteins with its key characteristic ability to form gels, protect intestinal tract against infectious agents9,10 and facilitate movement.

As mucins play a key role in the protection of the underlying epithelium, any quantitative change in mucus secretion may modify this defensive barrier and have important physiological implications. As GCs migrate up the colonic crypt, they synthesize, store, and secrete mucin-2 via regulate secretion11. Endogenous factors, such as acetylcholine (ACh) and serotonin, can trigger mucin-2 secretion from colonic GCs12,13. However, the effect of RE on colonic mucus secretion remains blurry. In this study, we aimed to investigate the RE conduct mucus secretion of colonic GCs with its underlying mechanism.

Results

Effects of short-term RE administration on faeces in rats

To investigate the effect of RE to increase the water excretion after the administration of RE to rats, the faecal granule number and faecal water content were determined over 24 h. Compared with that of the control group, the faecal water content in the group treated with 3 g/kg RE increased from 0.66 ± 0.12 mL/g (n = 11) to 0.64 ± 0.13 mL/g (p > 0.05, n = 11); in the groups treated with 6 g/kg and 9 g/kg RE, the respective faecal water content values increased to 1.45 ± 0.30 mL/g (p = 0.025, n = 11), and 1.84 ± 0.40 mL/g, (p = 0.001, n = 11). After pretreatment with ketotifen, the water content exhibited no obvious change, with a value of 0.75 ± 0.21 mL/g (p > 0.05, n = 11). After pretreatment with ketotifen 1 h later and treatment with RE at a dose of 6 g/kg subsequently, the water content was increased compared to that of the control group, with a value of 0.92 ± 0.20 mL/g (p > 0.05, n = 11). The faecal pellet number exhibited the same trend as the water content, as shown in Fig. 1a–c. The number of particles excreted from faeces exhibited the same trend as the water content, as shown in Fig. 1a–c. Ratio of moisture content for the weight of faeces in the control were 36.66%. With 3 g/kg, 6 g/kg and 9 g/kg RE given, the ratio of water content in faeces showed an increasing trend as 35.17%, 52.72%, 58.00% respectively, which has no difference ratio of water content in faeces between the control group and the group with treatment ketotifen. Administration ketotifen 1 h and addition with RE at a dose of 6 g/kg subsequently, the ratio of the water content in faeces is up to 42.35% (Fig. 1d).

Figure 1
figure1

Effect of ketotifen on RE-evoked colonic faeces changes. (a) Concentration-response relationship for RE -evoked ahead or treatment with ketotifen for 24 h on faeces. (b,c,e) The bar graph illustrates the quantities of faeces (F = 16.02, P < 0.0001) and the water (F = 4.063, P = 0.003) and histamine content (F = 2.638, P = 0.347) in feces after administration of RE alone and treatment with ketotifen. (d) Moisture accounts for the wet weight of feces in the different groups (F = 3.319, P = 0.01). Data are presented as the mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001.

At same time, the content of histamine in the faeces decreased from 3.22 ± 0.27 ng/mg (n = 9)in the control group to 2.87 ± 0.14 ng/mg, which represents a decrease of 10.86% (p > 0.05, n = 9), in the group treated with 3 g/kg RE. In addition, this value decreased to 1.58 ± 0.19 ng/mg, which represents a decrease of 50.93% (p = 0.003, n = 9), in the group treated with 6 g/kg RE. However, no significant decrease, with a value of 2.81 ± 0.30 ng/mg and a reduction of 12.73% (p > 0.05, n = 9), was observed in the group treated with 9 g/kg RE. After pretreatment with ketotifen, the content of histamine in the faeces decreased to 2.92 ± 0.59 ng/mg, which represents a reduction of 9.31% (p > 0.05, n = 9). However, this value was 3.14 ± 0.49 ng/mg, with a slightly increasing trend (p > 0.05, n = 9), in the group treated with ketotifen and RE (Fig. 1e). From all these results, we could speculate that RE may increase defecation, and histamine released from mast cells might involve in this process.

Distribution and quantification of mast cells in the colon after the administration of RE in rats

Just as previous studies have reported that rhubarb can cause degranulation of mast cells14, which could enhance transepithelial water secretion by acting on H receptor15. In order to exam the changes of the distribution and quantification of mast cells in the colon after the administration of RE in rats, as shown in Fig. 2a,c, the migration and accumulation of mast cells were observed in the colon tissue specimen after DAB staining and the detection of CD117 positive cell, mast/stem cell growth factor receptor (SCFR), which is a receptor tyrosine kinase that is also known as proto-oncogene c-Kit or tyrosine protein kinase Kit16. The number of CD117 positive cells increased from 10.33 ± 2.26 (n = 8, 200×) in the control group to 53.00 ± 8.73 in the group treated with 3 g/kg RE, which represents an increase of 413.06% (p < 0.001, n = 8, 200×), and 70.33 ± 3.07 (p < 0.001, n = 8, 200×) in the group treated with 6 g/kg RE, about 580.83% increase. Although the increase in the group treated with 9 g/kg RE was not as large as the increases observed in the other two groups, the value was to 27.67 ± 1.48 (p = 0.019, n = 8, 200×), also enhancement about 167.86%. The results obtained from immunofluorescence and Western blotting were consistent with the results of DAB staining (Fig. 2b,d). As expected, the levels of chymase, a marker of activated mast cells, was significantly enhanced about 80.05% (p = 0.003, n = 11), 137.11% (p < 0.001, n = 10) and 91.64% (p = 0.003, n = 9), at doses of 3 g/kg, 6 g/kg and 9 g/kg RE, respectively. These results showed that RE might play a potential role in promoting the aggregation and activation of colonic mast cells in rats.

Figure 2
figure2

Immunohistochemistry detection of the mast cells on the rat distal colon. (a) Changes in the number of CD117+ mast cells with DAB staining in the rat colon. (b) Changes in mast cells observed with immunofluorescence in the rat colon. Mast cell chymase is shown in green. (c) The bar graph illustrates the changes in mast cells number with different doses of RE alone by means of DAB. (F = 30.45, P < 0.0001). (d) Western blotting quantified the expression of mast cell chymase in the rat colon. Densitometric analysis of chymase protein levels normalized to β-tubulin. Data are presented as the mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001.

Change in GC quantity and colonic mucus secretion after administration of RE or ketotifen in vivo

We observed the changes in mucus secretion and GC activity that occurred when different doses of RE were administered to rats. “Sentinel” goblet cells (senGCs) localize to the colonic crypt entrance. These cells endocytose nonspecifically and protect the colonic crypt from bacterial intruders that have penetrated the inner mucus layer to maintain colonic mucoid bilayer stability17.

In order to directly identify RE-involved in mucous secretion of goblet cells in colon, light microscopy was used to observe the intensity of staining and count the GCs under 200×magnification. As Fig. 3a shown, the results indicate that the number of GCs was 120.2 ± 6.34 high power field (HPF) (n = 12) in the control group. This value was significant enhanced to 156.6 ± 13.12 HPF by 30.0% (p = 0.012, n = 9), and to 163.7 ± 12.56 HPF about 35.83% (p = 0.002, n = 12), in the groups subjected to gavage administration of RE at doses of 3 g/kg and 6 g/kg, respectively. While the number of GCs slightly decreased with no significant change, to 111.3 ± 9.01 HPF of 7.40% (n = 11, p > 0.05), in the group subjected to gavage administration of RE at a dose of 9 g/kg. All these results suggest that RE may increase GC numbers. While the number of GCs was 132.8 ± 8.18 HPF (n = 8, p > 0.05) in the group of treatment ketotifen at the 0.30 g/kg, which was not obviously different from that of the control group, while administration with ketotifen 1 h ahead by gavage RE at a dose of 6 g/kg, the number of GCs is obviously increased to 157.8 ± 7.02 HPF (p = 0.021, n = 8) compared with the number observed after treatment with RE alone, The result imply that mast cells might be partly involved in this process. The number of senGCs was 0.60 ± 0.40 HPF (n = 12) in the control group. At the same time the SenGCs were also observed the SenGCs number was obviously enhanced from0.60 ± 0.40 HPF (n = 12) to 3.0 ± 0.37 HPF (p = 0.013, n = 8), 6.14 ± 0.74 HPF (p < 0.001, n = 8), and 3.83 ± 0.54 HPF (p = 0.001, n = 8) in the groups subjected to gavage administration of RE at doses of 3 g/kg, 6 g/kg and 9 g/kg, respectively. At same time, the number of senGCs enhanced to 3.25 ± 0.65 HPF (p = 0.004, n = 8) in the group subjected to gavage administration of ketotifen alone compared with that of the control group, which was also significant increase to 3.83 ± 0.60 HPF (p = 0.001, n = 8) in the group subjected to gavage administration of ketotifen ahead and RE at a dose of 6 g/kg subsequently(Fig. 3b). SenGCs exhibited changes similar to those observed for GCs and RE plays a role in GC mucus secretion.

Figure 3
figure3

Pharmacology of RE-induced the change in GC number and content of mucus secretion. (a) Changes in GC number and mucin secretion by PAS/AB in the rat colon under a 200× field. Red arrows refer to senGCs. (b) The bar graph illustrates the change in GC (F = 4.978, P = 0.0008) and senGC (F = 8.219, P < 0.0001) numbers with different doses of RE ahead and treatment with ketotifen by PAS/AB under HPF. (c) RE-induced Ach (F = 5.032, P = 0009), histamine (F = 4.913, P = 0.001), Mucin-2 (F = 5.436, P = 0006) released from mucosa/submucosa preparations of the rat colon with different doses of RE and treatment with ketotifen. (d) Representative traces of RE effects on colonic secretion in vitro with the intestinal perfusion system and quantitative analysis using the Bradford protein assay kit. Data are presented as the mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001.

RE-induced ACh and histamine release ex vivo

As Fig. 4 shown, by immunofluorescence, it was noticed that there are much mucin-2 vesicles in the GC cytoplasm, and the H1 and H2 receptors are distributed in the colonic GC membrane, especially on the basal side. In order to determine whether RE could stimulate ACh and histamine release, the contents of ACh, histamine and mucin-2 in the colon tissue were measured with ELISA from different groups after incubation. As shown in Fig. 3c, under basal condition, the ACh content in the colonic tissues was 10.66 ± 0.38 U/mg (n = 9). When the colonic tissue was incubated at RE doses of 20 μg/ml, 40 μg/ml and 80 μg/ml, the ACh contents of the tissue decreased to 9.57 ± 0.37 U/mg about 10.20% (p > 0.05, n = 9); 8.38 ± 0.60 U/mg, by 21.39% (p = 0.004, n = 9); and 7.58 ± 0.87 U/mg by 28.93% (p < 0.001, n = 9), respectively. After pretreatment with ketotifen at the concentration of 100 μM, the ACh content was 10.37 ± 0.44 U/mg (p > 0.05, n = 9), with no significant change to the control group; in contrast, after pretreatment with ketotifen ahead and RE at a concentration of 40 μg/ml subsequently, the ACh content of the colon tissue decreased to 8.68 ± 0.37 U/mg by 18.60% (p = 0.012, n = 9) compared with the content of the control group.

Figure 4
figure4

Location of Mucin-2 and HR with immunofluorescence in the rat colon Green fluorescence is mucin-2, and red fluorescence represents H1R and H2R, respectively. The eight pictures on the left are under a 400× field. The two pictures on the right are at 800× magnification. Scale as 100 µm and 50 µm.

As shown in Fig. 3c, pretreatment with RE at concentrations of 20 μg/mL, 40 μg/mL and 80 μg/mL, the histamine content is decreased from 5.77 ± 0.33 ng/mg (n = 9) to 5.65 ± 0.14 ng/mg about 2.07% (p > 0.05, n = 9); 5.09 ± 0.21 ng/mg about 11.79% (p > 0.05, n = 9); and 4.56 ± 0.44 ng/mg about 20.97% (p = 0.005, n = 9), respectively. The results indicated that the trend of histamine change was similar to that of Ach. In the colon preparations, ketotifen (100 μM) caused stronger reduction of RE (40 μg/mL)-induced histamine release from 6.40 ± 0.37 ng/mg (p > 0.05, n = 9), to and 5.18 ± 0.12 ng/mg (p > 0.05, n = 9) in pretreatment with ketotifen and RE at a concentration of 40 μg/m. These results suggest that RE -induced enhancement of histamine was partly mediated by mast cell activation.

It is well known that intestinal mucus, being high-molecular-mass glycoproteins, are secreted by GCs and form a highly hydrated mucus gel that coats the epithelial surface of the intestinal tract18. In order to further verify the efficacy of rhubarb in moistening intestines and relieving constipation, the content of mucin-2, the main component of mucus in the colonic tissues, was also measured. Under basal conditions, the mucin-2 content was 1.45 ± 0.10 ng/mg (n = 9). Similarly pretreatment with RE at concentrations of 20 μg/ml, 40 μg/ml and 80 μg/ml, resulted reduction in 8.77% (p > 0.05, n = 9) to 1.32 ± 0.05 ng/mg; 23.54% (p = 0.005, n = 8) to 1.11 ± 0.07 ng/mg, 38%(p < 0.001, n = 8) to 0.98 ± 0.09 ng/mg respectively. While pretreatment with ketotifen alone or ketotifen 10 mins later then adding RE at a dose of 40 μg/ml, the mucin-2 content in tissues was 1.44 ± 0.09 ng/mg (p > 0.05, n = 8) or 1.33 ± 0.09 μg/mg by19.82%(p > 0.05, n = 8), respectively.

To further test the hypothesis that GC- derived mucus is involved in RE-induced colonic mucus secretion, Elisa was used to measure mucus secretion from the rat colon sample following RE treatment. As shown in Fig. 3d, after an equilibration time of 40 min as the basal condition following RE treatment, mucin-2 accumulation in perfusate of the colon tissues was as control. Pretreatment of the tissues with RE at a concentration of 40 μg/ml in the perfusion chambers. There was a sustained enhancement of mucus secretion especially in the point of time from 0.16 ± 0.03 mg/ml (n = 9) to 0.30 ± 0.04 mg/ ml by 87.5% (p = 0.016, n = 10) at the fortieth min, from 0.15 ± 0.02 mg/ml (n = 9) to 0.32 ± 0.07 mg/ml by 113.33% (p = 0.019, n = 9) at the forty-fifth min, from 0.14 ± 0.03 mg/ ml (n = 9) to 0.27 ± 0.03 mg/ml by 92.86% (p = 0.012, n = 10) at the fiftieth min, and from 0.13 ± 0.04 mg/ ml (n = 9) to 0.26 ± 0.03 mg/ml by 100.00% (p = 0.013, n = 10) at the fifty-fifth min respectively. These results suggest that RE can promote colonic mucus secretion. While pretreatment of the tissues with ketotifen 10 min prior to RE, the content of mucin reduced significantly by 31.83% (p = 0.002, n = 10) within 20 mins of drug treatment compared with treatment RE alone. All these results suggest that the RE-induced secretion of mucin-2 was partially mediated by mast cell activation.

Identification of rhubarb and intestinal allergy

In order to authenticate the relationship between the increase of intestinal mucus secretion and defecation caused by RE and intestinal allergic reaction, IgE and IgA in colon tissue were detected by ELISA and DAB staining. As the Supplementary Figure 2 shown, pretreatment with RE at doses of 3 g/kg, 6 g/kg and 9 g/kg with gavage for 3 days, the concentration of the IgE in the colon tissue was an increasing trend by 31.7%, 49.35% and 46.05% (F = 13.78, p < 0.0001). To further confirm that RE induce IgE releasing from mast cell, treatment with ketotifen at the dose of 1 mg/kg alone, the concentration of the IgE in the colon tissue was slightly reduced compared with control group. After treatment with ketotifen 1 h later and addition with RE at the dose of 6 g/kg, it was found that the content of IgE in colon tissues is increased significantly about 30.85%. Interestingly, the ratio of CD79a positive cell for B-cell markers and its DAB mean intensity have the same trend as IgE change as shown in Supplementary Fig. 3.

Effect of RE on serum cytokines in rats

Numerous studies have shown that mucus secretion is mediated by serum cytokines19,20. To test to what extent the cytokines involve in the process of the intragastric administration at doses of 3 g/kg, 6 g/kg, and 9 g/kg for three days. As shown in Fig. 5, there is no significant change in the content of IL-1and IL-6 in serum. The content of TNF-α exhibited an increasing trend, but with no obviously difference compared with the control group (p > 0.05). There was a significant increase of the content of IFN-γ from 184.5 ± 5.35 ng/L(n = 8) in the control group to 220.9 ± 12.76 ng/l by 19.72% (p = 0.010, n = 8) 193.6 ± 4.11 ng/L in the group with 6 g/kg RE treated, but with no obviously change by5.72% (p > 0.05, n = 8) and 1.13% (p > 0.05, n = 9) in the groups treated with 3 g/kg and 9 g/kg RE treated, respectively. At same time, the content of IL-10 was visibly reduced from 144.8 ± 7.09 pg/mL (n = 8) in the control group to 114.3 ± 5.91 pg/mL about 21.06% (p = 0.002, n = 9), 111.8 ± 4.16 pg/ml about of 22.79% (p = 0.004, n = 9) at RE doses of 3 g/kg and 6 g/kg, respectively. In contrast, the content of IL-10 was not down-regulated in dose of with RE at 9 g/kg (Fig. 5c). This result suggested RE could induce / restrain the changes of some cytokines such as IFN-γ and IL-10, which may involve in the process of regulating mucus secretion.

Figure 5
figure5

Effects of RE on changes of serum cytokine. (ae) Concentration-response relationship for RE-evoked changes of IL-1 (F = 0.348, P > 0.05), IL-6 (F = 0.326, P > 0.05), IL-10 (F = 7.756, P = 0.0005), TNF-α (F = 1.048, P > 0.05) and INF-ɣ (F = 3.236, P = 0.036). Data are presented as the mean ± S.E.M. *P < 0.05, **P < 0.01.

Discussion

Rhubarb has long been used to treat constipation, and the earliest record can be found in Shen Nong’s Herbal Classic, which is currently still used in the preparation of herbal laxatives for thousands of years. However, it remains unknown how a laxative effect of rhubarb act on the colon tissue to regulate mucin secretion. This present study aimed to investigate the mechanisms underlying RE-induced mucus secretion in vivo and ex vivo.

It has been reported that the secretion of mucus is accompanied with water5,21. In clinical practice, the water content in stool will increase after applying rhubarb for 6–12 hours, though such short term rhubarb application (once/day for 3 days) will not cause dehydration. The side effects of rhubarb is limited due to the application of rhubarb in clinic is usually less than a week; and long-term use anthraquinone laxatives may lead to melanosis coli, as was shown in many studies22,23,24. Anthraquinones, as the main active ingredients of the Chinese rhubarb, tomato leaves and radix polygoni multiflori, are usually considered to be the chemical basis of the purgative activity of rhubarb. The associated regulatory mechanism might involve two aspects, one of which is the stimulation and irritation of the gastrointestinal tract, which promotes colonic peristalsis and accelerates colonic transit significantly25; on the other hand, it can increase paracellular permeability and result in an enhancement of the water content in the colon lumen26,27. Our previous study found that emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons7. However, the mechnism of rhubarb-induced mucus secretion remain obscure. Our study reveals that treatment with RE results in the aggregation and activation of mast cells, increase histamine release and chymase, markers of mast cells. Degranulation of mast cells causes the release of mast cell mediators, which stimulate mucus secretion by directly acting on goblet cells28. The specialized function of GCs is the synthesis and secretion of mucus. Mucin-2 is a component of the intestinal mucus, especially in the colon. As mucus play a vital role in the protection of the underlying epithelium, any quantitative change in mucus secretion may modify this defensive barrier. Mucus is a viscous gel composed mainly of water (90% or more), with small amounts of salts, carbohydrates, lipids and mucins29. It was recorded in the Chinese Compendium of Medica that RE has the function of moistening the intestines and promoting bowel movements. Depending on the goal of the research, the identification of GCs may be relevant. Particle tracking after the oral administration of RE in rats, for instance, showed clearly that the number of GCs increased, and the content of mucus were also increased. These findings suggested that mast cells participate in increasing the colonic water content to soothe constipation or cause diarrhoea with the protective mechanisms30. It is deduced that RE induced-mucus secretion, which could be partially blocked by ketotifen, a mast cell membrane stabilizer. IgE is the lowest level of total antibodies in normal environment31. The level of IgE was significantly increased in serum in the case of food allergy and intestinal parasite infection, which was closely related to the occurrence of allergic symptoms32. IgA plays a key role in the immune function of intestinal mucosa. Intestinal tract stimulated by various antigens and cytokines produced by mucosal T cells, accelerated the conversion of B cells to IgA cells33. Simultaneously, IgA is involved in the regulation of allergic reaction34. It can increase the output of IgA and has a strong neutralizing effect to inhibit allergic reaction35. Local IgE and IgA levels increased as Supplementary Figs. 2, 3. Degranulation of mucosal mast cells in the gut triggers a type I hypersensitivity response, which is characterized by powerful propulsive muscular contractions and hypersecretion that underlie a diarrhea state36.

There is mounting evidence for interactions between the mucus secretion and enteric neurons, and immune cells37. Mast cells are closely associated with nerve fibers in the intestine, because of the proximity of mast cells and neural fibers, spontaneous release of mast cell mediators modulates neural reflex programs, which regulate goblet cell function38,39,40. As an important role in anaphylaxis, mast cell could quickly degranulate and release some bioactive components including chemokines, which cause smooth muscle contraction, increase in permeability and eosinophils aggregation in the lamina propria mucosa41. ACh and histamine are important neurotransmitters in the submucosal plexus that mediate intestinal secretion42,43. As seen in Fig. 1e, Fig. 3c and Fig. 6, in addition to mast cells, eosinophils also accumulated with the administration of RE, which might limit the activity of basophils in many ways and relieve allergic reactions44. We consider that Ach and histamine from mast cells may precipitate mucus secretion via secretagogues mucus, which might contribute to the laxative effect, which can be partly inhibited by ketotifen.

Figure 6
figure6

Effect of RE on Eosinophils in the colon. (a) RE-evoked eosinophil accumulation by H&E staining of the rat colon. (b) The bar graph illustrates the changes in eosinophils number with different doses of RE alone. (F = 33.61, P < 0.0001) Data are presented as the mean ± S.E.M. ***P < 0.001. Scale as 50 µm.

Some interleukins are pro-inflammatory factors, such as TNF-α, IL-1 and IL-6, which play a role in the acute response. IL-6 is an important modulator in maintaining the balance between Th1 and Th2 cell effector functions. IL-10 directly relieves endoplasmic reticulum stress, promotes GC differentiation, and increases the biosynthesis and secretion of mucin-2, depending on activation of STAT1 and STAT3 during inflammation45. Previous reports have shown that IL-10 plays a vital role in the stimulation and maintenance of tolerance to benign allergens. In allergic rhinitis and asthma, airway IL-10 expression is reduced. In turn, this reduction leads to inflammation in response to non-harmful allergens46. In our experiments, there was a significant reduction in the level of IL-10 in the groups treated with 3 g/kg and 6 g/kg RE, which suggests that rhubarb caused a slight allergic reaction. However, IL-1, IL-6 and TNF-α exhibited no differences compared to the control group. Interestingly, IFN-γ increased in the 6 g/kg group. It was also reported that IL-6 signalling via membrane-bound IL-6R leads to activation of the immune system mainly through anti-inflammatory pathways in response to invading pathogens, in addition to the pro-inflammatory mechanism. The data presented herein suggest that different doses of RE caused different types of hypersensitivity or that IL-6 also participated in two mechanisms caused by the action of RE. Moreover, IL-6 has an direct/indirect regulatory effect on mucus secretion47 (Fig. 7).

Figure 7
figure7

An illustration of the working hypothesis of Rhubarb-Evoke Mucus Secretion in colon. RE may stimulates mast cells to release histamine, which binds to the HR on cholinergic neurons and leads to ACh release. ACh and histamine might induce the release of IL-10 and IL-6. IL-10 could increase mucin secretion through the IL-10 receptor on GCs. IL-6 may also lead to an enhancement of mucin secretion, which may be caused by down-regulation via IFN-γ. In the figure, solid arrows represent direct excitation, dotted arrows represent indirect excitation, the T indicates inhibition.

Summarizing, the question of the in vivo and ex vivo significance of the direct effect of RE on mucus secretion must be raised. It can be postulated that changes of cytokines and mucus hypersecretion depend on RE-induced mast cell degranulation of colon and submucosal cholinergic neurons and partly non-neuronal pathway.

Materials and Methods

Animals and experimental design

All animal protocols followed the guidelines established by the National Institutes of Health and were approved by the Animal Care and Use Committee of Capital Medical University (IRB number: AEEI-2016-079). Male Sprague-Dawley (SD) rats (Laboratory Animal Services Center, Capital Medical University), weight ranging from 220 to 250 g (6 weeks old), had free access to standard rodent laboratory food and water until the day of the experiments. A total of 110 rats were randomly divided into different groups just as the RE therapeutic groups (3 g/kg, 6 g/kg, and 9 g/kg body weight), the control group treated with physiological saline and ketotifen treatment group. All drugs were given via intragastric administration for three days in the in vivo experiments. One group of rats was fed ketotifen fumarate tablets at an oral dose of 1 mg/kg 1 h before the administration of RE, and one group of rats was fed the ketotifen fumarate tablets alone. In this study, the animal were measured daily for its body weight, food intake and defecation volume. The animals were killed by cervical dislocation. Forty rats were used in the incubation test and the colon perfusion test in vitro

Drugs

Polygonum multiflorum rhubarb roots were purchased from Beijing Tong Ren Tang, Beijing, China. As described previously7, the air-dried roots were powdered, extracted by soaking for 2 h and boiling gently for 2 h and stored at 4 °C until use, and the samples were authenticated by Prof. Wen Wang, a botanist at Xuanwu Hospital in Beijing, China. The extract was diluted to 1 g/ml RE. Ketotifen fumarate was produced by Sigma (USA, Lot number: 080M1565V) and Tokyo Chemical Industry (TCI, Lot number: K0048). Krebs-Henseit solution (K-HS) includes the following ingredients (in mM) at pH 7.4: NaCl, 117; KCl, 4.5, CaCl2, 2.5; MgCl2, 1.2; NaHCO3, 24.8; KH2PO4, 1.2; and glucose, 11.1. (Supplementary Table 1)

Faecal pellet output and water content

The rats were kept individually in stainless steel metabolism crates in an environmentally controlled (27 ± 2 °C) room, the bottoms of which remained open and in a moist environment to minimize the risk of water evaporation and coprophagia. Faecal samples were collected after 12 h, weighed (wet weight), desiccated under natural ventilation (37 °C, 24 h), and weighed again (dry weight). The faecal water content was calculated according to the formula:

$${\rm{Water}}\,{\rm{content}}( \% )=\frac{{\rm{wet}}\,{\rm{weight}}-{\rm{dry}}\,{\rm{weight}}}{{\rm{wet}}\,{\rm{weight}}}\times 100 \% $$

Histopathology and immunohistochemistry

The isolated distal colon (DC, 1.5 cm to anus) samples were cut along the mesenteric border and flushed with Krebs–Henseleit solution (K–HS). Tissue specimens were fixed overnight with 4% paraformaldehyde (PFA), embedded in optimal cutting temperature (OCT) or paraffin, sliced at a 5 μm step thickness (Leica, CM1850, St. Gallen, Switzerland) and air-dried for 24 h at room temperature. The sections were immersed in a beaker containing citrate buffer (0.01 M, pH 6.0) and boiled at 95–100 °C in a microwave for 15 min for antigen retrieval. Slices were stained with 3,3′-Diaminobenzidine (DAB), Periodic Acid-Schiff/Alcian blue (PAS/AB) and haematoxylin after incubation with an anti-mast cell CD117 antibody, according to the product descriptions (Zhongshan, PV-6001, China, and Genmed Scientifics, Inc., GMS30062.4, USA). For immunofluorescence, the following steps were performed. After being washed with phosphate-buffered saline (PBS) for 5 min, the sections were incubated with 5% normal donkey serum in 0.3% Triton X-100 in PBS for 30 min at room temperature and then incubated with primary antibodies overnight at 4 °C. Subsequently, the sections were washed with PBS with Tween 20 (PBST) and incubated with the appropriate secondary antibodies at room temperature for 2 h. 4,6-Diamidino-2-phenylindole (DAPI) was used to stain the cell nuclei. Finally, the specimens were mounted with anti-fade glycerol buffer. Images were captured by using a laser confocal TCSSP5 microscope. The antibodies against histamine receptors were purchased from Abgent (H1 receptor: AF3587a, H2 receptor: AF2455a), the antibody against CD117 was purchased from Thermo Fisher Scientific (MA-170079), and the antibody against mucin-2 was purchased from Santa Cruz (Sc-15334). (Supplementary Table 1)

Western blotting

Colon samples were homogenized in cold lysis buffer with protease inhibitor cocktail (Roche, Switzerland). The extracts were subjected to electrophoresis in polyacrylamide gels, transferred to nitrocellulose (NC) membranes (Millipore, USA) and blocked with non-fat milk dissolved in Tris-buffered saline (TBS) for 1 h. The NC membranes were incubated with primary antibodies to detect endogenous levels of total β-tubulin protein (Gxybio, P1014) and mast cell chymase (Abcam, Ab2377) overnight at 4 °C and then for 2 h at room temperature, followed by incubation with the appropriate secondary antibodies for 2 h at room temperature. The blots were visualized by using an Odyssey Infrared Imager (LI-COR, NE, USA). (Supplementary Table 1)

Quantification of colonic mucus levels

The amount of mucus secreted from the colonic segments in vitro was evaluated as previously standard procedures detailed in described48. Segments of the colon (approximately 1 cm in length) were equilibrated in Ussing chambers, with 950 mL/L O2 and 50 mL/L CO2 in K-HS at 37 °C for 15 min. The tissues were then incubated with Kreb’s solution with an qual volume of saline was as the control, RE at the different dosage of 20 μg/mL, 40 μg/mL and 80 μg/mL L, ketotifen at the concentration of 100 μM or pretreatment with ketotifen 10 min then add RE (40 μg/mL) for 40 min. Then, the tissues samples were collected for measurements.

Enzyme-linked immunosorbent assay

The contents of histamine, ACh and mucin-2 released from the colonic segments in vitro were measured by means of ELISA as previously described49. Faeces were soaked overnight in PBS at 4 °C and centrifuged at 8000 rpm. The supernatants were constant volume and samples of the same volume were collected to measure the concentration of histamine in the faeces. Serum was obtained by centrifugation after blood collection and was used to measure the concentrations of IFN-γ, TNF-α, IL-1, IL-6, and IL-10. ELISA kits (Biotechnology Co., Ltd., Beijing, China) were used to measure the cytokines mentioned above according to the manufacturer’s protocols. (Supplementary Table 1)

Colon perfusion test and protein content detection

Male SD rats weighing 250–300 g (Laboratory Animal Services Center, Capital Medical University) were housed in group cages under conditions of controlled temperature (22–24 °C) and illumination (12-h light cycle starting at 6:00 AM) before experiments are maintained on laboratory chow and water. Protocols describing the use of rats were approved by the Animal Care and Use Committee, Capital Medical University and in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The rats were anaesthetized with 10% chloral hydrate at a dose of 4 mL/kg. The abdominal cavities were cut and opened along the midline incision to obtain the colons (7 cm, DC, 1.5 cm to anus). Then, the colons tissue were washed with Kreb’s solution, placed in a perfusion slot (Patent number: ZL 2015 2 0899585.5), which contained K-HS with 950 mL/L O2 and 50 mL/L CO2, and maintained at 37 °C. The intestinal segments were tied at one end and mounted with a plastic pipe made with a pipette tip at the other end. The colons segments were incubated in thermostatic baths for 15 min; then the flow rate of the peristaltic pump was adjusted to 1 mL/5 min, and the outflow solution was collected at the outlet per 5 min. The samples of the control, treatment with RE at concentration of 40 μg/mL and treatment with ketotifen (100 μM) add RE (40 μg/mL) were collected in the order listed. Ketotifen was administered after three rounds of outflow solution were collected, when the colons have adapted to the environment. The outflow solution was collected into Eppendorf tubes and analysed with a Bradford protein concentration kit (Beyotime, P0006, China), as described in the manufacturer’s protocol. (Supplementary Table 1)

Data presentation and analysis

Slices were stained with haematoxylin and eosin (H&E). The granules in eosinophils were dyed red, and positive cells were observed tissue sections from at least three tissues of five animals. All tissue specimens stained for HE, PAS/AB or CD117 were taken at a 200× magnification, sampling a total area of 2.5 mm2 of each slide at least four but generally six random images for microscopic evaluation of the intestinal structures and cells by an experienced pathologist in a blinded manner. The colour intensity of the NIS-Elements BR 4.10 software was set to find the target in the slices and analyse the number and chromaticity of stained cells. GCs were also counted using this method after staining with PAS/AB.

Images displayed CD79a positive cells were analyzed using the dedicated software, TissueQuest (TissueGnostics GmbH, Vienna, Austria), which can provide the algorithms for DAB positive cell authentication. The software is able to set cutoffs automatically using a class 2 cutoff algorithm according to the standard of non-reactive control primary antibodies. Or cutoffs can be identified by the operator, that is to say, background and signal intensity could be analyzed automatically using the software. Tissue virtual microscopy analyses were performed using the soft system that combines detailed morphologic information offered by microscopy with the scientific accuracy of multichannel flow cytometry. Results of the imaging analyses were expressed as total number of CD79a positive cells, and total number of effective cells. Then, it was possible to accurately quantify the percentage of cells positive for CD79a markers in each analyzed tissue samples in a fast and no bias scanning. Cell density was calculated as total number of the cells divided by total sample area in square millimeters. The same cutoff values were maintained for each marker and comparison to minimize error rate. 0.5 mm × 0.5 mm of six casual fields were analyzed for each sample. There are at least four animals in each group.

All values were expressed as the means ± standard errors of the mean (S.E.M.), and n is the number of animals in each experiment. All data were analyzed using the GraphPad Prism 5.0 software package (GraphPad Software Inc., San Diego, CA, USA). Differences among groups were analyzed by one-way analysis of variance (ANOVA) with Dunnett’s post-hoc test. A P value less than 0.05 was considered statistically significant.

Data availability

The data in this study generated during and/or analyzed during the current study and supplementary information are available from the corresponding author on reasonable request.

References

  1. 1.

    Chen, D. C., Yang, X. Y., Zhang, X. Y. & Chen, X. Y. Protective effect of rhubarb on the intestinal mucosal barrier. World J Gastroenterol 3, 81–83, https://doi.org/10.3748/wjg.v3.i2.81 (1997).

  2. 2.

    Chen, D. C. & Wang, L. Mechanisms of therapeutic effects of rhubarb on gut origin sepsis. Chin J Traumatol 12, 365–369 (2009).

  3. 3.

    Fang, F. et al. A comparative study on the tissue distributions of rhubarb anthraquinones in normal and CCl4-injured rats orally administered rhubarb extract. J Ethnopharmacol 137, 1492–1497, https://doi.org/10.1016/j.jep.2011.08.028 (2011).

  4. 4.

    Wei, S. Y., Yao, W. X., Ji, W. Y., Wei, J. Q. & Peng, S. Q. Qualitative and quantitative analysis of anthraquinones in rhubarbs by high performance liquid chromatography with diode array detector and mass spectrometry. Food Chem 141, 1710–1715 (2013).

  5. 5.

    Sydiskis, R. J., Owen, D. G., Lohr, J. L., Rosler, K. H. & Blomster, R. N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 35, 2463–2466 (1991).

  6. 6.

    Ali, S., Watson, M. S. & Osborne, R. H. The stimulant cathartic, emodin, contracts the rat isolated ileum by triggering release of endogenous acetylcholine. Auton Autacoid Pharmacol 24, 103–105 (2004).

  7. 7.

    Xu, J. D., Wang, W., Li, L. S., Chen, X. & Zhu, J. X. Involvement of endogenous prostaglandin in emodin-evoked rat colonic anion secretion. Biol Pharm Bull 30, 2058–2062 (2007).

  8. 8.

    Liu, P. et al. Oral colon-specific drug delivery system reduces the nephrotoxicity of rhubarb anthraquinones when they produce purgative efficacy. Experimental and therapeutic medicine 14, 3589–3601, https://doi.org/10.3892/etm.2017.4959 (2017).

  9. 9.

    Furness, J. B., Rivera, L. R., Cho, H. J., Bravo, D. M. & Callaghan, B. The gut as a sensory organ. Nature reviews. Gastroenterology & hepatology 10, 729–740, https://doi.org/10.1038/nrgastro.2013.180 (2013).

  10. 10.

    Van Spaendonk, H. et al. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol 23, 2106–2123, https://doi.org/10.3748/wjg.v23.i12.2106 (2017).

  11. 11.

    Safaee, M. et al. The role of epidermal growth factor-like module containing mucin-like hormone receptor 2 in human cancers. Oncology reviews 8, 242, https://doi.org/10.4081/oncol.2014.242 (2014).

  12. 12.

    Taherali, F., Varum, F. & Basit, A. W. A slippery slope: On the origin, role and physiology of mucus. Adv Drug Deliv Rev 124, 16–33, https://doi.org/10.1016/j.addr.2017.10.014 (2018).

  13. 13.

    Johansson, M. E., Sjovall, H. & Hansson, G. C. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10, 352–361, https://doi.org/10.1038/nrgastro.2013.35 (2013).

  14. 14.

    Liu, Y. et al. Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation. Phytotherapy research: PTR 22, 935–942, https://doi.org/10.1002/ptr.2429 (2008).

  15. 15.

    Keely, S. J., Stack, W. A., O’Donoghue, D. P. & Baird, A. W. Regulation of ion transport by histamine in human colon. European journal of pharmacology 279, 203–209, https://doi.org/10.1016/0014-2999(95)00156-f (1995).

  16. 16.

    Foster, B. M., Zaidi, D., Young, T. R., Mobley, M. E. & Kerr, B. A. CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. Biomedicines 6, https://doi.org/10.3390/biomedicines6010031 (2018).

  17. 17.

    Birchenough, G. M., Nystrom, E. E., Johansson, M. E. & Hansson, G. C. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352, 1535–1542, https://doi.org/10.1126/science.aaf7419 (2016).

  18. 18.

    Luo, Q. et al. Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect Immun 82, 509–521, https://doi.org/10.1128/IAI.01106-13 (2014).

  19. 19.

    Takahashi, S., Nakamura, E. & Okabe, S. Effects of cytokines, without and with Helicobacter pylori components, on mucus secretion by cultured gastric epithelial cells. Digestive diseases and sciences 43, 2301–2308, https://doi.org/10.1023/a:1026635110099 (1998).

  20. 20.

    Basso, D. et al. Different effects of H. pylori water extracts on cytokines, pepsinogen C and gastrin mucosal release in patients with or without duodenal ulcer. Journal of medicine 32, 97–112 (2001).

  21. 21.

    Dufour, P. & Gendre, P. Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration. Gut 25, 1358–1363 (1984).

  22. 22.

    Chen, J. Y., Pan, F., Zhang, T., Xia, J. & Li, Y. J. Experimental study on the molecular mechanism of anthraquinone cathartics in inducing melanosis coli. Chinese journal of integrative medicine 17, 525–530, https://doi.org/10.1007/s11655-011-0786-z (2011).

  23. 23.

    Abendroth, A. et al. Impressive picture of a melanosis coli after chronic anthraquinone laxative use–is there an increased risk for colorectal cancer? Zeitschrift fur Gastroenterologie 47, 579–582, https://doi.org/10.1055/s-0028-1109056 (2009).

  24. 24.

    Walker, N. I., Bennett, R. E. & Axelsen, R. A. Melanosis coli. A consequence of anthraquinone-induced apoptosis of colonic epithelial cells. The American journal of pathology 131, 465–476 (1988).

  25. 25.

    Lv, S. Y., Yang, Y. J., Qin, Y. J., Xiong, W. & Chen, Q. Effect of centrally administered apelin-13 on gastric emptying and gastrointestinal transit in mice. Peptides 32, 978–982 (2011).

  26. 26.

    Lin-lin SHI, L.-n. X., Shu-guang Hou, Sen LIN, Hong YANG, Tong-hui MA. Activation Effect of Cathartic Natural Compound Rhein to CFTR Chloride Channel. Chemical Research in Chinese Universities 22, 312–314 (2006).

  27. 27.

    Wang, S. et al. Antidiarrheal effect of Alpinia oxyphylla Miq. (Zingiberaceae) in experimental mice and its possible mechanism of action. J Ethnopharmacol 168, 182–190, https://doi.org/10.1016/j.jep.2015.03.066 (2015).

  28. 28.

    Huang, H. T., Guo, J. J., Huang, Y. H. & Fu, Y. S. Histamine-induced changes in rat tracheal goblet cell mucin store and mucosal edema. Histochemistry and cell biology 139, 717–726, https://doi.org/10.1007/s00418-012-1060-y (2013).

  29. 29.

    Bansil, R. & Turner, B. S. The biology of mucus: Composition, synthesis and organization. Adv Drug Deliv Rev 124, 3–15, https://doi.org/10.1016/j.addr.2017.09.023 (2018).

  30. 30.

    Jaggi, A. S., Kaur, G., Bali, A. & Singh, N. Pharmacological investigations on mast cell stabilizer and histamine receptor antagonists in vincristine-induced neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol 390, 1087–1096, https://doi.org/10.1007/s00210-017-1426-8 (2017).

  31. 31.

    Gadermaier, E. Determination of allergen specificity by heavy chains in grass pollen allergen-specific IgE antibodies (vol 131, pg 1185, 2013). J Allergy Clin Immun 132, 216–216 (2013).

  32. 32.

    Steele, L., Mayer, L. & Berin, M. C. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res 54, 75–82 (2012).

  33. 33.

    Boullier, S. & Tanguy MKadaoui, K. A. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol 183, 5879–5885 (2009).

  34. 34.

    Roth-Walter, F. et al. Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer’s patches. Allergy 63, 882–890, https://doi.org/10.1111/j.1398-9995.2008.01673.x (2008).

  35. 35.

    Smits, H. H. et al. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol 2, 331–339, https://doi.org/10.1038/mi.2009.16 (2009).

  36. 36.

    Cooke, H. J. Neuroimmune signaling in regulation of intestinal ion transport. The American journal of physiology 266, G167–178, https://doi.org/10.1152/ajpgi.1994.266.2.G167 (1994).

  37. 37.

    Bienenstock, J. The mucosal immunologic network. Annals of allergy 53, 535–540 (1984).

  38. 38.

    Botchkarev, V. A. et al. A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle–dependent changes in mast cell–nerve fiber contacts in murine skin. Archives of dermatological research 289, 292–302 (1997).

  39. 39.

    Kakurai, M. et al. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. The American journal of pathology 169, 1713–1721, https://doi.org/10.2353/ajpath.2006.060602 (2006).

  40. 40.

    Pilartz, M., Jess, T., Indefrei, D. & Schroder, J. M. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration. Acta neuropathologica 104, 513–524, https://doi.org/10.1007/s00401-002-0586-9 (2002).

  41. 41.

    Shimizu, T., Hirano, H., Majima, Y. & Sakakura, Y. A mechanism of antigen-induced mucus production in nasal epithelium of sensitized rats - A comparison with lipopolysaccharide-induced mucus production. Am J Resp Crit Care 161, 1648–1654 (2000).

  42. 42.

    Karaki, S. I. & Kuwahara, A. Regulation of intestinal secretion involved in the interaction between neurotransmitters and prostaglandin E2. Neurogastroenterol Motil 16(Suppl 1), 96–99, https://doi.org/10.1111/j.1743-3150.2004.00482.x (2004).

  43. 43.

    Gao, Z. G. & Jacobson, K. A. Purinergic Signaling in Mast Cell Degranulation and Asthma. Front Pharmacol 8, 947, https://doi.org/10.3389/fphar.2017.00947 (2017).

  44. 44.

    Gotlib, J. & Akin, C. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders. Semin Hematol 49, 128–137, https://doi.org/10.1053/j.seminhematol.2012.01.007 (2012).

  45. 45.

    Hasnain, S. Z. et al. IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology 144, 357–368 e359, https://doi.org/10.1053/j.gastro.2012.10.043 (2013).

  46. 46.

    Branchett, W. J. & Lloyd, C. M. Regulatory cytokine function in the respiratory tract. Mucosal immunology 12, 589–600, https://doi.org/10.1038/s41385-019-0158-0 (2019).

  47. 47.

    Neveu, W. A. et al. IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens. J Immunol 183, 1732–1738, https://doi.org/10.4049/jimmunol.0802923 (2009).

  48. 48.

    Ramnarine, S. I., Khawaja, A. M., Barnes, P. J. & Rogers, D. F. Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro. Brit J Pharmacol 118, 998–1002 (1996).

  49. 49.

    Eutamene, H. et al. Involvement of interleukin-1, prostaglandins and mast cells in rectal distension-induced colonic water secretion in rats. The Journal of physiology 506(Pt 1), 245–252 (1998).

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China Grant (No. 81673671, 81274173 JD Xu and 81270443 LS Li), Beijing National Science Foundation (No. 7122017. JD Xu)

Author information

D.W., F.L. and J.X. carried out the experiments. D.W., X.X., C.G., T.W. and Y.L. performed the Western blotting and morphological investigations. L.L. provided the reagents and materials. X.T. and J.X. designed the experiments and provided helpful English language advice. All authors reviewed the manuscript.

Correspondence to Jingdong Xu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wu, D., Xue, X., Gao, C. et al. Rhubarb-Evoke Mucus Secretion through Aggregation and Degranulation of Mast Cell in the Colon of Rat: In vivo and ex vivo studies. Sci Rep 9, 19375 (2019). https://doi.org/10.1038/s41598-019-55937-7

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.